Evolent Health (EVH) Revenue (2015 - 2026)

Evolent Health's Revenue history runs 12 years deep, the most recent figure standing at $496.2 million for Q1 2026.

• In Q1 2026, Revenue rose 2.6% year-over-year to $496.2 million; the TTM figure through Mar 2026 stood at $1.9 billion (down 21.26% YoY), while the FY2025 annual figure was $1.9 billion, down 26.56% from the prior year.
• Revenue was $496.2 million for Q1 2026 at Evolent Health, up from $468.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $647.1 million in Q2 2024 to a low of $297.1 million in Q1 2022.
• Historically, Revenue has averaged $484.9 million across 5 years, with a median of $479.5 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Revenue surged 58.49% in 2022, then plunged 31.34% in 2025.
• A 5-year view of Revenue shows it stood at $382.4 million in 2022, then jumped by 45.4% to $556.1 million in 2023, then climbed by 16.27% to $646.5 million in 2024, then slipped by 27.5% to $468.7 million in 2025, then increased by 5.87% to $496.2 million in 2026.
• The last three Revenue figures came in at $496.2 million (Q1 2026), $468.7 million (Q4 2025), and $479.5 million (Q3 2025), per Business Quant data.